Glucagen Hypokit

Glucagen Hypokit is a prescription‑only glucagon product supplied as a sterile solution for injection. The active ingredient is glucagon, a peptide hormone that raises blood glucose levels. It is marketed in the European Union and is administered by intramuscular, intravenous, or subcutaneous injection. The kit includes a single dose for rapid administration.

Glucagen Hypokit is indicated for the acute management of conditions that cause dangerously low blood glucose.

- Treatment of severe hypoglycemia in patients with diabetes when oral glucose is ineffective or unavailable. - Emergency reversal of insulin overdose in both adults and children. - Use in a clinical setting when rapid restoration of blood glucose is required, such as during surgery or diagnostic procedures. - Administration by trained personnel in out‑of‑hospital situations, including home or workplace emergencies. - Support for patients who are unconscious or unable to swallow oral carbohydrate preparations. - Provision of a rapid, non‑oral glucose source when intravenous dextrose infusion is not immediately accessible.

Glucagen Hypokit may cause a range of adverse reactions, most of which are transient and resolve without intervention.

Common: - Nausea or vomiting, usually mild and short‑lasting. - Flushing, warmth, or redness of the face and neck. - Headache that resolves within a few hours. - Dizziness or light‑headedness, especially when standing quickly. - Transient sweating or feeling of heat that usually subsides quickly.

Serious: - Severe allergic reaction (anaphylaxis) presenting with rash, itching, swelling, or breathing difficulty. - Rapid heart rate (tachycardia) or irregular heartbeat that may require monitoring. - Low blood pressure (hypotension) leading to fainting or dizziness. - Seizures or convulsions, which are very rare but require immediate medical attention. - Chest pain or discomfort that may indicate cardiac involvement and should be evaluated.

When using Glucagen Hypokit, certain precautions and warnings should be observed to ensure safe and effective treatment.

- Verify the correct patient and indication before administration. - Ensure the solution is clear and free of particles; do not use if discolored or contaminated. - Use only with a new, sterile needle and syringe as supplied. - Monitor blood glucose levels after administration and repeat dosing if hypoglycemia persists. - Be aware of possible allergic reactions; discontinue use and seek medical help if signs of anaphylaxis appear. - Store the kit according to the label, protecting it from extreme temperatures and light. - Do not administer to patients with known hypersensitivity to glucagon or any excipients.

Glucagen Hypokit may interact with certain medications or substances; awareness of these interactions helps prevent adverse outcomes.

Avoid: - Concurrent use with beta‑blockers may mask typical symptoms of hypoglycemia after glucagon administration.

Use with caution: - Caution when administered with other antihypoglycemic agents, as rapid glucose rise can lead to rebound hyperglycemia. - Use carefully in patients receiving catecholamines, as glucagon can potentiate cardiovascular effects. - Monitor closely if the patient is on MAO inhibitors, although significant interaction is uncommon. - Consider dose adjustment if the patient is receiving high‑dose insulin therapy. - Avoid simultaneous administration with other glucagon‑containing products to prevent overdose.